- Email: [email protected]
Corrigendum to “AFN-1252 in vitro absorption studies and pharmacokinetics following” [Eur. J. Pharm. 50 (3–4) (2013) 440–446]
European Journal of Pharmaceutical Sciences 52 (2014) 223
Contents lists available at ScienceDirect
European Journal of Pharmaceutical Sciences journal homepage: www.elsevier.com/locate/ejps
Corrigendum
Corrigendum to ‘‘AFN-1252 in vitro absorption studies and pharmacokinetics following’’ [Eur. J. Pharm. 50 (3–4) (2013) 440–446] Nachum Kaplan a,⇑, Colin Garner b,1, Barry Hafkin a a b
Affinium Pharmaceuticals, Inc., 200 Front Street West, Suite 3004, P.O. Box 31, Toronto, ON M5V 3K2, Canada Xceleron Ltd., York Biocentre, Innovation Way, Heslington, York YO10 5NY, UK
The author regrets as, in addition to the acknowledgment section, they would like to acknowledge the contribution of those staff at Xceleron Ltd., Kendle International BA, Absorption Systems and Biodynamics Research Ltd. who assisted us in providing the scientific findings reported here. The authors would like to apologise for any inconvenience caused.
DOI of original article: http://dx.doi.org/10.1016/j.ejps.2013.08.019
⇑ Corresponding author. Tel.: +1 416 645 6649. 1
E-mail addresses: [email protected] (N. Kaplan), [email protected] (C. Garner), [email protected] (B. Hafkin). Present address: Garner Consulting Services, York, UK.
0928-0987/$ - see front matter Ó 2013 Elsevier B.V. All rights reserved. http://dx.doi.org/10.1016/j.ejps.2013.11.014
Contents lists available at ScienceDirect
European Journal of Pharmaceutical Sciences journal homepage: www.elsevier.com/locate/ejps
Corrigendum
Corrigendum to ‘‘AFN-1252 in vitro absorption studies and pharmacokinetics following’’ [Eur. J. Pharm. 50 (3–4) (2013) 440–446] Nachum Kaplan a,⇑, Colin Garner b,1, Barry Hafkin a a b
Affinium Pharmaceuticals, Inc., 200 Front Street West, Suite 3004, P.O. Box 31, Toronto, ON M5V 3K2, Canada Xceleron Ltd., York Biocentre, Innovation Way, Heslington, York YO10 5NY, UK
The author regrets as, in addition to the acknowledgment section, they would like to acknowledge the contribution of those staff at Xceleron Ltd., Kendle International BA, Absorption Systems and Biodynamics Research Ltd. who assisted us in providing the scientific findings reported here. The authors would like to apologise for any inconvenience caused.
DOI of original article: http://dx.doi.org/10.1016/j.ejps.2013.08.019
⇑ Corresponding author. Tel.: +1 416 645 6649. 1
E-mail addresses: [email protected] (N. Kaplan), [email protected] (C. Garner), [email protected] (B. Hafkin). Present address: Garner Consulting Services, York, UK.
0928-0987/$ - see front matter Ó 2013 Elsevier B.V. All rights reserved. http://dx.doi.org/10.1016/j.ejps.2013.11.014